ClearBridge Investments’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$120M Buy
226,104
+50,138
+28% +$23.1M 0.1% 199
2026
Q1
$84.5M Sell
175,966
-29,216
-14% -$15M 0.07% 231
2025
Q4
$115M Sell
205,182
-51,382
-20% -$29.2M 0.09% 213
2025
Q3
$132M Sell
256,564
-7,345
-3% -$3.21M 0.1% 197
2025
Q2
$82.8M Sell
263,909
-131,186
-33% -$39.4M 0.07% 251
2025
Q1
$120M Sell
395,095
-14,616
-4% -$4.92M 0.11% 195
2024
Q4
$136M Sell
409,711
-8,194
-2% -$2.78M 0.11% 186
2024
Q3
$139M Buy
417,905
+14,013
+3% +$5.32M 0.11% 179
2024
Q2
$166M Buy
403,892
+143,481
+55% +$56.8M 0.14% 158
2024
Q1
$105M Buy
260,411
+195,698
+302% +$68.8M 0.08% 244
2023
Q4
$19.8M Buy
+64,713
New +$17.5M 0.02% 465
2017
Q3
Sell
-943
Closed -$27K 1204
2017
Q2
$27K Buy
943
+109
+13% +$3.06K ﹤0.01% 1001
2017
Q1
$25K Buy
834
+491
+143% +$15.8K ﹤0.01% 977
2016
Q4
$12K Buy
343
+241
+236% +$8.03K ﹤0.01% 1057
2016
Q3
$3K Buy
+102
New +$2.98K ﹤0.01% 1085

Other funds holding MEDP

ClearBridge Investments's MEDP Position: Q2 2026 in Review

ClearBridge Investments increased its Medpace (MEDP) stake by 28% in Q2 2026, buying an estimated $23.1M and bringing the position to 226,104 shares worth $120M. The position accounts for 0.1% of the portfolio, ranked #199.

ClearBridge Investments first reported a position in MEDP in Q3 2016 and has held it in 15 quarters since. The position peaked at $166M in Q2 2024. 547 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • ClearBridge Investments held 226,104 shares of Medpace worth $120M as of Q2 2026.
  • ClearBridge Investments bought 50,138 Medpace shares in Q2 2026, an estimated $23.1M.
  • Medpace made up 0.1% of ClearBridge Investments's portfolio in Q2 2026, its #199 holding.
  • ClearBridge Investments first reported a position in Medpace in Q3 2016 and has held it in 15 quarters since.
  • ClearBridge Investments's Medpace position peaked at $166M in Q2 2024.
  • 547 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on ClearBridge Investments's 13F filing for Q2 2026, filed 13 Aug 2026.